Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton

This publication has 58 references indexed in Scilit:

• Rapamycin: A bone sparing immunosuppressant?
  Journal of Bone and Mineral Research, 1995
• Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
  The Lancet, 1995
• Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat
  Calcified Tissue International, 1994
• THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO
  Transplantation, 1994
• Bone loss after liver transplantation
  Hepatology, 1991
• Cyclosporine-Induced Alterations in the Hypothalamic Hypophyseal Gonadal Axis in Transplant Patients
  Nephron, 1991
• Suppression of B cell activation by cyclosporin A, FK506 and rapamycin
  European Journal of Immunology, 1990
• Cyclosporine
  New England Journal of Medicine, 1989
• POTENTIAL PROTECTION BY CYCLOSPORIN AGAINST GLUCOCORTICOID EFFECTS ON BONE
  The Lancet, 1989
• Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia
  The Journal of Pediatrics, 1989